Argenx
ARGX
#456
Rank
โ‚ฌ44.66 B
Marketcap
721,71ย โ‚ฌ
Share price
-0.10%
Change (1 day)
14.94%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ44.66 Billion

As of February 2026 Argenx has a market cap of โ‚ฌ44.66 Billion. This makes Argenx the world's 456th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ44.66 B-0.29%
2025โ‚ฌ44.79 B24.46%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Argenx was reported to be:

โ‚ฌ44.01 Billion
by Nasdaq info icon info icon
โ‚ฌ44.66 Billion
by CompaniesMarketCap info icon info icon